• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

GENETIC POLYMORPHISM OF DRUG METABOLIZING-ENZYME ; ANALYSIS OF NOVEL POLYMORPHISM AND DEVELOPMENT OF GENOTYPING METHOD

Research Project

Project/Area Number 10557242
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field 応用薬理学・医療系薬学
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

ARIYOSHI Noritaka  Hokkaido Univ., Asso.Prof., 大学院・薬学研究科, 助教授 (00243957)

Co-Investigator(Kenkyū-buntansha) NAKAYAMA Kazuo  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (20261323)
TAKAHASHI Yoshiki  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (80292019)
FUJITA Ken-ichi  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (60281820)
MINE Tsuyoshi  Sumitomo Pharm., Senior Investigator, 主任研究員
KAMATAKI Tetsuya  Hokkaido Univ., Prof., 大学院・薬学研究科, 教授 (00009177)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2000: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1999: ¥1,900,000 (Direct Cost: ¥1,900,000)
Keywordsdrug metabolism / cytochrome P450 / genetic polymorphism / CYP2D6 / Adverse reaction / poor metabolizer / gene analysis / CYP2D6^*36 / 薬の効き過ぎ / 遺伝的解析 / CYP2D6^*10C / フレームシフト型変異
Research Abstract

CYP2D6 is a form of cytochrome P450(CYP)involved in the metabolism of more than 40 clinically important drugs including some tricyclic antidepressants, antiarrhythmics, b-adrenergic blockers and histamin H_1 antagonists. This form of CYP is polymorphically expressed in a population and characterized as two phenotypes, extensive metabolizers and poor metabolizers(PM). It was assumed that there may be some unknown polymorphisms in Orientals, because major variants in Caucasians could not fully account for the frequency of the PM in Japanese. Analysis of the CYP2D6 gene in two Japanese PMs identified by phenotyping using debrisoquine was performed. As a result, novel two mutations were discovered. was one-base insertion in exon 5, leading to generation a stop codon at 11 dp downstream. This variant was designated as the CYP2D6^*21. The other one was tandem repeat of inactive gene, CYP2D6^*36, at regions of the CYP2D locus. Genotyping method was established against each of the variant allele. The frequency of the CYP2D6^*36-^*36 could not be determined in this study due to small sise of subjects. On the other hand, the CYP2D6^*21 appeared to be one of the major variant causing PM phenotype in Japanese.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (44 results)

All Other

All Publications (44 results)

  • [Publications] Michihiro Chida et al.: "Analysis of short fragment amplified by LA-PCR for diagnosis of CYP2D6*5"Japanese Journal of Clinical Pharmacology and Therapeutics. 31. 433-434 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Michihiro Chida et al.: "A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype"Pharmacogenetics. 9. 287-293 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Michihiro Chida et al.: "Genetic polymorphism of CYP2D6 in Japanese population"Pharmacogenetics. 9. 601-609 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tomonori Tateishi et al.: "Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population"Clinical Pharmacology and Therapeutics. 65. 570-575 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Michihiro Chida et al.: "Relationship between genotype and phenotype of CYP2D6 in Japanese"Japanese Journal of Clinical Pharmacology and Therapeutics. 30. 81-82 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Michihiro Chida et al.: "Discovery of a new variant CYP2D6 allele (CYP2D6/Ch2-Ch2) in Japanese population"Japanese Journal of Clinical Pharmacology and Therapeutics. 29. 239-240 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 有吉範高: "月刊薬事3月臨時増刊号"じほう. 834 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 有吉範高: "薬物代謝学"東京化学同人. 282 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Noritaka Ariyoshi et al.: "A Single Nucleotide Polymorphism of CYP2B6 Found in Japanese Enhances Catalytic Activity by Autoactivation."Biochemical Biophysical Research Communications. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Noritaka Ariyoshi et al.: "A Novel Single Nucleotide Polymorphism Altering Stability and Activity of CYP2A6."Biochemical Biophysical Research Communications. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takeshi Ozeki et al.: "Cooperative regulation of the transcription of human dihydrodiol dehydrogenase (DD) 4/AKR1C4 gene by hepatocyte neclear factor (HNF) -4α/γ and HNF-1α."Biochemical Journal. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Noritaka Ariyoshi et al.: "Pharmacogenetics on cancer chemotherapy : from basic studies."Japanese Journal of Clinical Pharmacology and Therapeutics. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Taisei Mushiroda et al.: "Accumulation of the 1-methyl-4-phenylpyridinium ion (MPP+) in suncus (Suncus murinus) brain : Implication for flavin-containing monooxygenase activity in brain microvessels."Chemical Research in Toxicology. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Loriot, M-A et al.: "Genetic polymorphism of cytochrome P450 2A6 in a case control study on lung cancer in a French population."Pharmacogenetics. 11. 39-44 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Noritaka Ariyoshi et al.: "Studies on the genetic polymorphism of CYP2A6."Drug Metabolism and Disposition. 15. 57-61 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hirotaka Kushida et al.: "Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines : expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S.typhimurium YG7108."Mutation Research. 471. 135-143 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takashi Satoh et al.: "Studies on the interactions between drugs and estrogen. Analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli co-expressing human CYP3A4 with human NADPH-cytochrome P450 reductase."Analytical Biochemistry. 286. 179-186 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Noritaka Ariyoshi et al.: "Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C."Pharmacogenetics. 10. 678-693 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Taisei Mushiroda et al.: "The house musk shrew (Suncus murinus) : a unique animal with extremely low level of expression of mRNA for CYP3A and flavin-containing monooxygenase."Comparative Biochemistry & Physiology. 126. 225-234 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hirotaka Kushida et al.: "Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase."Carcinogenesis. 21. 1227-1232 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Eri Inoue et al.: "Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of Cytochrome P450."Biochemical Biophysical Research Communications. 269. 623-627 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Taisei Mushiroda et al.: "A high level expression of CYP2A in the lung of the Suncus (Suncus murinus) and its role in the Activation of 4- (methylntirosamino) -1- (3-pyridyl) -1-butanone (NNK)."Biochemical Biophysical Research Communications. 269. 393-396 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ken-ichi Fujita et al.: "Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1)."Life Science. 66. 1955-1967 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Noritaka Ariyoshi et al.: "Handbook of Experimental Pharmacology"Springer-VerlagBerlin. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 有吉範高: "月刊薬事2001年臨時増刊号"じほう. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 鎌滝哲也: "薬物療法学"南江堂. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 有吉範高: "月刊薬事3月臨時増刊号"じほう. 834 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 鎌滝哲也: "薬物代謝学"東京化学同人. 282 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Masami Miyamoto, et al.: "CYP2A6 gene deletion reduces susceptibiliy to lung cancer"Biochemical Biophysical Research Communications. 261. 658-660 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tomonori Tateishi, et al.: "Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capaciy in Japanese population"Clinical Pharmacology and Therapeutics. 65. 570-575 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kimihiko Matsusue, et al.: "A highly toxic coplanar polychlorinated biphenyl compound suppress △5 and △6 desaturase activities which play key roles in arachidonic acid synthesis in"Chemical Research in Toxicology. 12. 1158-1165 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Miki Nakajima, et al.: "Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene : effect on the CYP1A2 inducibility in humans"Journal of Biochemistry. 125. 803-808 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ken-ichi Nunoya, et al.: "CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidine-4-one hydrochloride in humans"Journal of Pharmacology and Experimental Therapeutics. 289. 437-442 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Michihiro Chida, et al.: "A new variant CYP2D6 allele(CYP2D6^*21) with a single insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype"Pharmacogenetics. 9. 287-293 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 有吉範高: "別冊 医学のあゆみ 消化器疾患"医歯薬出版株式会社. 562 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 鎌滝哲也: "薬物療法学"南山堂 (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Michihiro Chida et al.: "A new variant CYP2D6 allele(CYP2D6/C8)with a single insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype." Pharmacogenetics. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Katsunori Nakamura et al.: "Oxidation of histamine H_1 antagonist mequitazine is catalysed by cytochrome P450 2D6 in human liver microsomes." Journal of Pharmacology and Experimantal Theraputics. 284. 437-442 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tsuyoshi Yokoi et al.: "Genetic polymorphism of drug metabolizing enzyme:new mutations in CYP2D6 and CYP2A6 genes in Japanese" Pharmaceutical Research. 15(4). 517-524 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ken-ichi Nunoya et al.: "A new deleted allele in human cytochroma P4502A6(CYP2A6) gene found in human liver〜pyridyl)thiazolidin-4-one hydrochloride(SM-12502)." Pharmacogenetics. 8. 239-249 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hiroshi Iwata et al.: "High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli." Biochemical Pharmacology. 55. 1315-1325 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Takafumi Tasaki et al.: "Expression and characterization of dog CYP2D15 using baculovirus expression system" Journal of Biochemistry. 123. 162-168 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 鎌滝哲也、有吉範高: "環境と健康II" 株式会社 へるす出版, 310 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 鎌滝哲也、有吉範高: "呼吸器疾患における分子生物学の基礎とその臨床応用" 医学書院, 447 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi